{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:39:06Z","timestamp":1771922346190,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Urol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Upper urinary tract urothelial carcinoma (UTUC) is an uncommon malignancy of the urogenital tract with a wide range of clinical outcomes. While prognostic factors for bladder-based UC are established, less is known about tumors in other locations and the impact of socioeconomic disparities. This study uses a large national database to identify key demographic, clinical, and socioeconomic predictors of overall survival in UC patients, focusing on the primary tumor site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of 12,300 patients diagnosed with UC of the kidney and renal pelvis between 2004 and 2020 from the National Cancer Database (NCDB). Multivariable Cox proportional hazards regression was used to analyze the association between overall survival and factors including patient demographics, tumor characteristics, primary tumor site, and socioeconomic status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort was predominantly male (59%) and White (91%), with a mean age of 71 at diagnosis. Multivariable analysis identified several factors significantly associated with survival. Renal pelvis tumors, the most common primary site (84.9%), were associated with significantly improved survival (HR = 0.84; 95% CI: 0.8\u20130.9; p&amp;lt;0.001). Compared to males, females exhibited a 15% lower hazard of death (HR = 0.85; 95% CI: 0.81-0.90; p&amp;lt;0.001). Factors associated with worse survival included a higher Charlson-Deyo comorbidity score (HR = 1.51; 95% CI: 1.39-1.65; p&amp;lt;0.001) and advanced NCDB tumor stage. Socioeconomically, patients with higher income (HR = 0.82; 95% CI: 0.75-0.90; p&amp;lt;0.001) and private insurance or Medicare (HR = 0.70; 95% CI: 0.57-0.87; p&amp;lt;0.001) had improved survival. Adjuvant chemotherapy was associated with a lower hazard of death (HR = 0.84; 95% CI: 0.75-0.95; p=0.007), whereas primary radiation therapy was associated with a higher hazard of death (HR = 1.69; 95% CI: 1.54-1.86; p&amp;lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This large-scale analysis identifies the primary tumor site as a key prognostic factor in UC, with renal pelvis tumors demonstrating more favorable survival. The study also confirms the significant influence of comorbidity and tumor stage while uniquely highlighting that socioeconomic factors, such as income and insurance, are powerful predictors of outcome. These findings underscore the need for optimized, site-specific treatment strategies and concerted efforts to address healthcare inequities in the management of upper tract UC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fruro.2025.1647133","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:22:34Z","timestamp":1768540954000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Demographic and prognostic landscape of upper urinary tract urothelial carcinoma: an analysis of a national cancer database"],"prefix":"10.3389","volume":"5","author":[{"given":"Beau","family":"Hsia","sequence":"first","affiliation":[{"name":"Creighton University School of Medicine","place":["Phoenix, AZ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Moroz","sequence":"additional","affiliation":[{"name":"Grand Canyon University","place":["Phoenix, AZ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Sipes","sequence":"additional","affiliation":[{"name":"Grand Canyon University","place":["Phoenix, AZ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Chang","sequence":"additional","affiliation":[{"name":"University of South Florida Morsani College of Medicine","place":["Tampa, FL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Jundi","sequence":"additional","affiliation":[{"name":"Arizona State University","place":["Tempe, AZ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Rafie","sequence":"additional","affiliation":[{"name":"Midwestern University Arizona College of Osteopathic Medicine","place":["Glendale, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Silberstein","sequence":"additional","affiliation":[{"name":"CHI Health Creighton University Medical Center","place":["Omaha, NE, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abubakar","family":"Tauseef","sequence":"additional","affiliation":[{"name":"CHI Health Creighton University Medical Center","place":["Omaha, NE, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-urologic-cancers-papillary-urothelial-neoplasms","article-title":"Papillary urothelial neoplasms: clinical, histologic, and prognostic features","volume-title":"Urologic cancers","author":"Yu","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199909010-00019","article-title":"Recurrence and progression in low grade papillary urothelial tumors","volume":"162","author":"Holmang","year":"1999","journal-title":"J Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.03.052","article-title":"Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications","volume":"57","author":"Matthias","year":"2010","journal-title":"Eur Urol"},{"key":"B4","article-title":"Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder","volume":"1","author":"Allard","year":"1995","journal-title":"Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e16012","DOI":"10.7759\/cureus.16012","article-title":"Tumour behaviour of low-grade papillary urothelial carcinoma: a single-centre retrospective study","volume":"13","author":"Dutta","year":"2021","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21852","article-title":"Understanding urothelial carcinoma through cancer pathways","volume":"119","author":"Shultz","year":"2006","journal-title":"Int J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-014-0416-0","article-title":"Duration and intensity of tobacco smoking and the risk of papillary and non-papillary transitional cell carcinoma of the bladder","volume":"25","author":"Polesel","year":"2014","journal-title":"Cancer Causes Control"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.12.049","article-title":"Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)","volume":"185","author":"Mallin","year":"2011","journal-title":"J Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21037\/tau-21-291","article-title":"Radiation therapy for nonmetastatic medically inoperable upper-tract urothelial carcinoma","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Androl Urol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1186\/s12885-016-2832-x","article-title":"Incidence and survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014","volume":"16","author":"Andreassen","year":"2016","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/21681805.2018.1518926","article-title":"National incidence and survival of patients with non-invasive papillary urothelial carcinoma: a Danish population study","volume":"52","author":"Erikson","year":"2018","journal-title":"Scand J Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00029330-200611010-00010","article-title":"Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study","volume":"119","author":"Yang","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800268","article-title":"Impact of the 1998 World Health Organization\/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney","volume":"18","author":"Genega","year":"2005","journal-title":"Mod Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/2058738420925720","article-title":"Non-invasive papillary urothelial carcinoma, low-grade of the renal pelvis mimicking a xanthogranulomatous pyelonephritis in a male patient: A case report and review of literature","volume":"34","author":"Xie","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2165-4","article-title":"Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder","volume":"471","author":"Warzecha","year":"2017","journal-title":"Virchows Arch"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12521","DOI":"10.1038\/s41598-018-29987-2","article-title":"Racial differences in urinary bladder cancer in the United States","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.02.004","article-title":"Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature","volume":"37","author":"Foerster","year":"2019","journal-title":"Urol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2013.02.002","article-title":"Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis","volume":"37","author":"Abdollah","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.14440\/bladder.2015.39","article-title":"Disparities in overall and urothelial carcinoma specific mortality associated with healthcare insurance status","volume":"2","author":"Siddiqui","year":"2015","journal-title":"Bladder"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.04.006","article-title":"Female, black, and unmarried patients are more likely to present with metastatic bladder urothelial carcinoma","volume":"14","author":"Klaassen","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"}],"container-title":["Frontiers in Urology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2025.1647133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:34:23Z","timestamp":1771918463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2025.1647133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":21,"alternative-id":["10.3389\/fruro.2025.1647133"],"URL":"https:\/\/doi.org\/10.3389\/fruro.2025.1647133","relation":{},"ISSN":["2673-9828"],"issn-type":[{"value":"2673-9828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"1647133"}}